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Dr Ruth Bush (Temple, Tex). I congratulate Dr. Young and
the coauthors on the presentation of cost-effectiveness of endovas-
cular aneurysm repair. I also very much appreciate receiving the
manuscript well ahead of this meeting. I have the following ques-
tions and a comment:
1. This model takes into account the cost of repair. However, as
we all know, with endovascular aneurysm repair, the cost of
lifelong surveillance and secondary intervention does add to the
overall cost. Is there a way to include this in the model? And do
you think it matters, Dr. Young?
2. Some suggest that women should undergo intervention at
smaller aneurysm diameters due to differences in vessel size, and
we will hear about that later on today. Is there any way to
incorporate gender into this model?
3. As we all hear, almost on a daily basis, and I believe President
Obama is meeting with the AMA next week, health care reform
is near the top or at the top of the current administration’s
agenda. How do you see your conclusions fitting in or influ-
encing that agenda?
And my last thing to say is a comment. I believe your data set
is robust, your statistical analysis is exact and on target, and I would
encourage you, after reviewing the manuscript, that the purpose,results. I found those very good. Again, I appreciate the opportu-
nity to review this paper.
Dr Young. Gender is included inherently in the model based
on the probabilities of rupture and growth.
In terms of surveillance, costs for this after endovascular and
after open repair are assumed to be equal and thus wouldn’t
contribute to the incremental cost-effectiveness ratio. If one
requires more surveillance than the other, it is possible it could
change the incremental cost-effectiveness ratio, likely making
EVAR more expensive. This scenario would still favor waiting
because open repair is more cost-effective. None of the cost
assumptions in my model affected the results, but it is possible.
With a public health hat, we certainly need more information
from surgeons as to what the best size to intervene is, what are the
risks, and what are the benefits. This model and the information we
have collected can certainly be refined as more data become
available to help address these questions.
Dr Benjamin Starnes (Seattle, Wash). You’ve looked at the
cost-effectiveness using a Markov model of analysis and quality-
adjusted life-years based on size of the aneurysm. What are your
thoughts – and this is just asking you what your personal opinion
is – on a comparison of cost-effectiveness of screening for abdom-
inal aortic aneurysms versus the cost-effectiveness of treating a
ruptured aneurysm? Can you comment on that?
Dr Young.No. I’m not familiar with the cost-effectiveness for
screening of abdominal aortic aneurysms.
